Eli Lilly and Company
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $28.53B | $14.27B | $3.27B |
| FY2025 | $40.87B | $26.54B | $7.27B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $28.53B | $14.27B | $3.27B |
| FY2025 | $40.87B | $26.54B | $7.27B |